EQL Pharma AB

At a glance

Most recent filing on November 18, 2018 — an option exercise by Annica Brising on Nov 13, 2018.

We hold 15 visible filings, going back to November 13, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 15 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 15. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Annica Brising Closely associated: Business Development Director
9,000 sharesOption exercise
TradedNov 13, 2018FiledNov 18, 2018
Björn Allan Beermann Chief financial officer
12,145 sharesOption exercise
TradedNov 14, 2018FiledNov 16, 2018
Chenjie Xu Closely associated: Chief executive officer
10,300 sharesOption exercise
TradedNov 13, 2018FiledNov 16, 2018
Teodor Brising Closely associated: Business Development Director
2,300 sharesOption exercise
TradedNov 13, 2018FiledNov 16, 2018
Cecilia Brising Closely associated: Business Development Director
2,300 sharesOption exercise
TradedNov 13, 2018FiledNov 16, 2018